Appears On
Episode Appearances
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Under scrutiny for leadership amid FDA reorganization, personnel issues, and perceived political interference; 50-50 odds of surviving month”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis